2,654
edits
No edit summary |
No edit summary |
||
(9 intermediate revisions by the same user not shown) | |||
Line 93: | Line 93: | ||
|1020 | |1020 | ||
|11/22/06 | |11/22/06 | ||
|10/ | |10/01/18 | ||
| | |10/01/18 | ||
|- | |- | ||
|[[Reduction in Force]] | |[[Reduction in Force]] | ||
Line 105: | Line 105: | ||
|1049 | |1049 | ||
|11/01/06 | |11/01/06 | ||
| | |08/23/18 | ||
| | |08/23/18 | ||
|- | |- | ||
|[[Political Activities]] | |[[Political Activities]] | ||
Line 211: | Line 211: | ||
|07/08/09 | |07/08/09 | ||
|11/30/12 | |11/30/12 | ||
|- | |- | ||
|[[Latex Sensitivity]] | |[[Latex Sensitivity]] | ||
Line 393: | Line 387: | ||
|8006 | |8006 | ||
|03/13/09 | |03/13/09 | ||
| | |08/23/18 | ||
| | |08/23/18 | ||
|- | |- | ||
|[[Use of Human Anatomical Material]] | |[[Use of Human Anatomical Material]] | ||
Line 404: | Line 398: | ||
|[[Clinical Research and Clinical Trial Professional and Technical Fee Billing]] | |[[Clinical Research and Clinical Trial Professional and Technical Fee Billing]] | ||
|8008 | |8008 | ||
| | |08/23/18 | ||
| | | | ||
| | | | ||
|- | |- | ||
|[[Contracts]] | |[[Contracts]] | ||
|8009 | |8009 | ||
|11/01/06 | |11/01/06 | ||
| | |10/30/18 | ||
| | |10/30/18 | ||
|- | |- | ||
|[[Conflict of Interest]] | |[[Conflict of Interest]] | ||
|8010 | |8010 | ||
|09/04/07 | |09/04/07 | ||
| | |08/23/18 | ||
| | |08/23/18 | ||
|- | |- | ||
|[[Red Flag Identity Theft Prevention Program]] | |[[Red Flag Identity Theft Prevention Program]] | ||
Line 430: | Line 424: | ||
|08/01/10 | |08/01/10 | ||
|05/12/17 | |05/12/17 | ||
| | |11/30/18 | ||
|- | |- | ||
|[[Human Tissue Use and Transfer]] | |[[Human Tissue Use and Transfer]] | ||
|8013 | |8013 | ||
|03/15/12 | |03/15/12 | ||
| | |07/30/18 | ||
| | |07/30/18 | ||
|- | |- | ||
|[[International Research Policy]] | |[[International Research Policy]] | ||
Line 447: | Line 441: | ||
|8015 | |8015 | ||
|08/31/15 | |08/31/15 | ||
| | |08/23/18 | ||
| | |08/23/18 | ||
|- | |- | ||
|[[Credit Hour Definition]] | |[[Credit Hour Definition]] | ||
Line 454: | Line 448: | ||
|11/28/16 | |11/28/16 | ||
|08/08/17 | |08/08/17 | ||
| | |12/07/18 | ||
|- | |- | ||
|[[Whistleblower]] | |[[Whistleblower]] | ||
Line 479: | Line 473: | ||
|6045 | |6045 | ||
|11/21/03 | |11/21/03 | ||
| | |08/28/18 | ||
| | |08/28/18 | ||
|- | |- | ||
|[[Computer Use/Electronic Information]] | |[[Computer Use/Electronic Information]] | ||
Line 697: | Line 691: | ||
|6072 | |6072 | ||
|11/19/07 | |11/19/07 | ||
| | |01/24/19 DRAFT | ||
| | | | ||
|- | |- | ||
|[[Academic Personnel Records]] | |[[Academic Personnel Records]] | ||
Line 751: | Line 745: | ||
|6083 | |6083 | ||
|05/01/13 | |05/01/13 | ||
| | |11/20/18 | ||
| | |11/20/18 | ||
|- | |- | ||
|[[Accounts Receivable Management]] | |[[Accounts Receivable Management]] | ||
Line 766: | Line 760: | ||
|04/24/18 | |04/24/18 | ||
|- | |- | ||
|[[Regulations on the Use of University Facilities and Grounds]] | |||
|6086 | |||
|12/13/18 | |||
| | |||
| | | | ||
<big>'''Intellectual Property Policies'''</big> | |- | ||
|<big>'''Intellectual Property Policies'''</big> | |||
|- | |- | ||
|[[Science/Technology Committee]] | |[[Science/Technology Committee]] |